Favorable Outcomes in Elderly Patients Undergoing High-Dose Therapy and Autologous Stem Cell Transplantation for Non-Hodgkin Lymphoma

High-dose therapy and autologous stem cell transplantation (HDT-ASCT) can offer potential long-term remission or cure in patients with non-Hodgkin lymphoma (NHL). Limited experience is available on the safety and efficacy of HDT-ASCT in elderly patients. This is a single-center, retrospective study...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Biol Blood Marrow Transplant
Autors principals: Dahi, Parastoo B., Tamari, Roni, Devlin, Sean M., Maloy, Molly, Bhatt, Valkal, Scordo, Michael, Goldberg, Jenna, Zelenetz, Andrew D., Hamlin, Paul A., Matasar, Matthew J., Maragulia, Jocelyn, Giralt, Sergio A., Perales, Miguel-Angel, Moskowitz, Craig H., Sauter, Craig S.
Format: Artigo
Idioma:Inglês
Publicat: 2014
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5480286/
https://ncbi.nlm.nih.gov/pubmed/25175794
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2014.08.019
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars